Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Head and Neck Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 87 articles: HTML format

Single Articles

February 2026
1. PEREZ-LEAL M, Estornut C, Alfaro-Ochoa L, Sanchez-Herrera G, et al
   Cigarette smoke induces expression of senescence markers and pro-inflammatory SASP in oral mucosa: Potential implications for early carcinogenic processes.
   Int J Cancer. 2026;158:752-762.
   PubMed     Abstract available
   
   
   December 2025
2. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
   Reply to 'Comment on "Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis"'.
   Int J Cancer. 2025 Dec 18. doi: 10.1002/ijc.70292.
   PubMed    
   
   
   
3. MISRA SR, Das R
   Comments on "Evaluating ChatGPT's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors".
   Int J Cancer. 2025 Dec 17. doi: 10.1002/ijc.70303.
   PubMed    
   
   
   
4. KRAEMER M, Wirsik NM, Alakus H, Schloesser HA, et al
   Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvant chemotherapy.
   Int J Cancer. 2025;157:2558-2568.
   PubMed     Abstract available
   
   
   
5. SOMAY E, Bascil S, Topkan E, Selek U, et al
   Comment on "Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis".
   Int J Cancer. 2025 Dec 15. doi: 10.1002/ijc.70290.
   PubMed    
   
   
   
6. IMLIMTHAN S, Bahrami K, Pehkonen H, Centanni A, et al
   Biological evaluation of a glucose-based boron carrier as a potential agent for boron neutron capture therapy.
   Int J Cancer. 2025;157:2374-2384.
   PubMed     Abstract available
   
   
   November 2025
7. WANG Y, Xi Y, Qiao L, Yu Y, et al
   Ethnic, sex, and age disparities in esophageal cancer and medical costs: A population-based study of 18 million people in China.
   Int J Cancer. 2025 Nov 11. doi: 10.1002/ijc.70236.
   PubMed     Abstract available
   
   
   October 2025
8. JIANG KY, Hu WL, Liu SX, Wang L, et al
   Efficacy of adjuvant immunotherapy and immunochemotherapy in esophageal squamous cell carcinoma: A retrospective cohort study.
   Int J Cancer. 2025 Oct 28. doi: 10.1002/ijc.70214.
   PubMed     Abstract available
   
   
   
9. NASMAN T, Birgersson M, Marklund L, Nasman A, et al
   Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)-associated tonsillar squamous cell carcinoma (TSCC).
   Int J Cancer. 2025 Oct 23. doi: 10.1002/ijc.70207.
   PubMed     Abstract available
   
   
   
10. SU Q, Feng R, Du S, Zhao H, et al
    Urinary mycotoxins and esophageal cancer risk in China: A case-cohort study.
    Int J Cancer. 2025 Oct 20. doi: 10.1002/ijc.70206.
    PubMed     Abstract available
    
    
    
11. HAN W, Gao L, Wang X, Li C, et al
    Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial.
    Int J Cancer. 2025 Oct 15. doi: 10.1002/ijc.70176.
    PubMed     Abstract available
    
    
    September 2025
12. VERHOEVEN RHA, Kuijper SC, Slingerland M, Wijnhoven B, et al
    Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival.
    Int J Cancer. 2025 Sep 23. doi: 10.1002/ijc.70168.
    PubMed     Abstract available
    
    
    
13. OSWAL K, Barman S, Kerr AR, Zaman M, et al
    Oral cancer risk stratification: A cross-sectional population-based screening study in Northeast India.
    Int J Cancer. 2025 Sep 19. doi: 10.1002/ijc.70160.
    PubMed     Abstract available
    
    
    
14. VAN DER VEN RGFM, van Erning FN, Westra DD, de Hingh IHJT, et al
    Nationwide trends and the impact of an oncology hospital network on reducing the burden of thyroid cytology procedures.
    Int J Cancer. 2025;157:1120-1129.
    PubMed     Abstract available
    
    
    
15. AMURE MT, Madathil SA, Laprise C, Rousseau MC, et al
    Oral co-infection with multiple alpha-human papillomavirus and head and neck cancer risk.
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70124.
    PubMed     Abstract available
    
    
    
16. DENNIS CD, Cohen DJ, Debnath K, Schwartz N, et al
    24R,25(OH)(2)D(3) regulates tumorigenesis in estrogen sensitive laryngeal cancer cells via membrane-associated receptor complexes in ER+ and ER- cells.
    Int J Cancer. 2025 Sep 8. doi: 10.1002/ijc.70141.
    PubMed     Abstract available
    
    
    August 2025
17. LI ZZ, Wei LY, Cao LM, Wang GR, et al
    Neck management in cT1-2N0 oral squamous cell carcinoma: Act or watchful wait?
    Int J Cancer. 2025;157:614-626.
    PubMed     Abstract available
    
    
    
18. MA S, Zhang Y, Xie S, Li X, et al
    Balanced diet quality and risk of upper gastrointestinal cancers: Insights from a prospective cohort study in China.
    Int J Cancer. 2025;157:658-671.
    PubMed     Abstract available
    
    
    
19. NASMAN A, Birgersson M, Nasman T, Jortso E, et al
    Age and tumour presentations differ between HPV type 16 positive and other high-risk HPV type-positive oropharyngeal squamous cell carcinomas in a Swedish cohort of 2000-2022.
    Int J Cancer. 2025 Aug 15. doi: 10.1002/ijc.70087.
    PubMed     Abstract available
    
    
    
20. ZHANG LT, Wu XY, Zhang HY, Li EM, et al
    Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma.
    Int J Cancer. 2025 Aug 11. doi: 10.1002/ijc.70080.
    PubMed     Abstract available
    
    
    July 2025
21. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis.
    Int J Cancer. 2025 Jul 30. doi: 10.1002/ijc.70033.
    PubMed     Abstract available
    
    
    
22. YAN D, Wang L, Huang L, Cheng K, et al
    Evaluating ChatGPT's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors.
    Int J Cancer. 2025 Jul 19. doi: 10.1002/ijc.70001.
    PubMed     Abstract available
    
    
    
23. WANG J, Wang L, Wang T, Tang T, et al
    Eye-sparing treatment for sinonasal tumors invading the orbit in the era of personalized therapy.
    Int J Cancer. 2025;157:151-160.
    PubMed     Abstract available
    
    
    June 2025
24. SONG XY, Lin L, Yang Y, Hu HH, et al
    Radiotherapy as an organ-preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy.
    Int J Cancer. 2025 Jun 25. doi: 10.1002/ijc.35515.
    PubMed     Abstract available
    
    
    
25. MODESTO A, Gibert S, Delmas C, Tougeron D, et al
    Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer.
    Int J Cancer. 2025 Jun 20. doi: 10.1002/ijc.70011.
    PubMed     Abstract available
    
    
    
26. GEERTS JFM, Vissers PAJ, Mostert B, Wijnhoven BPL, et al
    Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population-based study in the Netherlands.
    Int J Cancer. 2025 Jun 5. doi: 10.1002/ijc.35491.
    PubMed     Abstract available
    
    
    
27. CHAN WC, Millwood I, Kartsonaki C, Du H, et al
    Adiposity and risks of gastrointestinal cancers: A 10-year prospective study of 0.5 million Chinese adults.
    Int J Cancer. 2025;156:2094-2106.
    PubMed     Abstract available
    
    
    May 2025
28. LIN H, Ma J, Heng Y, Zhu X, et al
    CD8(+) T cells in patients with hypopharyngeal squamous cell carcinoma are susceptible to radiation-induced damage.
    Int J Cancer. 2025;156:2010-2023.
    PubMed     Abstract available
    
    
    
29. YAN L, Lin Y, Lin W, Hong J, et al
    Treatment outcomes in nasopharyngeal carcinoma patients with parotid lymph node metastasis: An 11-year experience at a tertiary cancer center.
    Int J Cancer. 2025 May 7. doi: 10.1002/ijc.35470.
    PubMed     Abstract available
    
    
    March 2025
30. LAN K, Liu S, Li S, Sun X, et al
    Comparing outcomes and toxicities among patients with nasopharyngeal carcinoma treated with daytime versus evening radiotherapy: A retrospective analysis with propensity score matching.
    Int J Cancer. 2025 Mar 29. doi: 10.1002/ijc.35408.
    PubMed     Abstract available
    
    
    
31. 
    Correction to "Chronotherapy in head and neck cancer: A systematic review and meta-analysis".
    Int J Cancer. 2025 Mar 7. doi: 10.1002/ijc.35396.
    PubMed    
    
    
    February 2025
32. HU Y, Lu T, Zhang H, Chen B, et al
    Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort study.
    Int J Cancer. 2025 Feb 24. doi: 10.1002/ijc.35382.
    PubMed     Abstract available
    
    
    
33. WANG H, Fan T, Lu Y, Que L, et al
    Baseline audiometric assessment of newly diagnosed nasopharyngeal carcinoma patients: a multicentre cross-sectional study.
    Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35358.
    PubMed     Abstract available
    
    
    January 2025
34. XIAO Z, Chen W, Du Y, Zeng F, et al
    Efficacy and safety of Anlotinib in combination with gemcitabine and cisplatin as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A single-arm clinical trial.
    Int J Cancer. 2025 Jan 18. doi: 10.1002/ijc.35340.
    PubMed     Abstract available
    
    
    
35. POISSONNET V, Uro-Coste E, Chabrillac E, Modesto A, et al
    Malignant salivary gland tumors of the tongue: A multicenter REFCOR study.
    Int J Cancer. 2025;156:310-321.
    PubMed     Abstract available
    
    
    
36. ZHAO R, Yuan H, Chen S, Xu K, et al
    Impact of accelerated biological aging and genetic variation on esophageal adenocarcinoma: Joint and interaction effect in a prospective cohort.
    Int J Cancer. 2025;156:299-309.
    PubMed     Abstract available
    
    
    
37. SLOTMAN E, Pape M, van Laarhoven HWM, Pouw RE, et al
    Considerations to forgo systemic treatment in patients with advanced esophageal or gastric cancer: A real-world evidence study.
    Int J Cancer. 2025 Jan 9. doi: 10.1002/ijc.35314.
    PubMed     Abstract available
    
    
    December 2024
38. WANG J, Li B, Zhang Y, Luo X, et al
    Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trial.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35261.
    PubMed     Abstract available
    
    
    
39. JHAWAR SR, Haring C, Pan X, Ma J, et al
    Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes in HPV-associated oropharyngeal cancer.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35291.
    PubMed     Abstract available
    
    
    
40. NORONHA V, Patil VM, Menon N, Goud S, et al
    Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer.
    Int J Cancer. 2024;155:2232-2245.
    PubMed     Abstract available
    
    
    
41. SEWASTJANOW-SILVA M, Kwiatkowski E, Yamashita K, Abdelhakeem A, et al
    Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.
    Int J Cancer. 2024;155:2277-2286.
    PubMed     Abstract available
    
    
    
42. INOUE-CHOI M, Freedman ND, Etemadi A, Hashemian M, et al
    One-carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study.
    Int J Cancer. 2024;155:1944-1957.
    PubMed     Abstract available
    
    
    November 2024
43. JIN ZY, Liu K, Wallar G, Zhou JY, et al
    Environmental tobacco smoking (ETS) and esophageal cancer: A population-based case-control study in Jiangsu Province, China.
    Int J Cancer. 2024 Nov 18. doi: 10.1002/ijc.35254.
    PubMed     Abstract available
    
    
    
44. ABUSAMAK M, Abu-Samak AA, Cai W, Al-Waeli H, et al
    Chronotherapy in head and neck cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35234.
    PubMed     Abstract available
    
    
    
45. RUTKOWSKI TW, Kurczyk A, Drosik-Rutowicz K, Kiprian D, et al
    Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Results of Polish multicenter observational study.
    Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35248.
    PubMed     Abstract available
    
    
    
46. KARIMI A, Mohebbi E, Mckay-Chopin S, Hadji M, et al
    Association of opium use and tobacco smoking with alpha-, beta-, and gamma-human papillomavirus oral infection.
    Int J Cancer. 2024;155:1544-1548.
    PubMed     Abstract available
    
    
    
47. SCHEI-ANDERSEN AJ, Hendricks LAJ, van der Post RS, Mensenkamp AR, et al
    Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center study.
    Int J Cancer. 2024;155:1567-1576.
    PubMed     Abstract available
    
    
    October 2024
48. 
    RETRACTION: A Multiplicity of Anti-Invasive Effects of Farnesyl Transferase Inhibitor SCH66336 in Human Head and Neck Cancer.
    Int J Cancer. 2024 Oct 22. doi: 10.1002/ijc.35230.
    PubMed     Abstract available
    
    
    
49. HSU WL, Tao J, Fu S, Yu KJ, et al
    Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex families.
    Int J Cancer. 2024;155:1400-1408.
    PubMed     Abstract available
    
    
    
50. SHEN Y, You Z, Li L, Tang X, et al
    The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis.
    Int J Cancer. 2024;155:1290-1302.
    PubMed     Abstract available
    
    
    
51. YAN X, Zeng H, Li H, Cao M, et al
    The current infection with Helicobacter pylori and association with upper gastrointestinal lesions and risk of upper gastrointestinal cancer: Insights from multicenter population-based cohort study.
    Int J Cancer. 2024;155:1203-1211.
    PubMed     Abstract available
    
    
    September 2024
52. WANG W, Ye L, Li H, Chen W, et al
    A narrative review on advances in neoadjuvant immunotherapy for esophageal cancer: Molecular biomarkers and future directions.
    Int J Cancer. 2024 Sep 14. doi: 10.1002/ijc.35153.
    PubMed     Abstract available
    
    
    
53. PIRES C, Marques IJ, Saramago A, Moura MM, et al
    Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways.
    Int J Cancer. 2024 Sep 9. doi: 10.1002/ijc.35159.
    PubMed     Abstract available
    
    
    
54. IWAKI S, Kawakita D, Nagao T, Tada Y, et al
    Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan.
    Int J Cancer. 2024;155:871-882.
    PubMed     Abstract available
    
    
    August 2024
55. JANKE F, Stritzke F, Dvornikovich K, Franke H, et al
    Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy.
    Int J Cancer. 2024 Aug 30. doi: 10.1002/ijc.35152.
    PubMed     Abstract available
    
    
    
56. SHI X, Lu M, Li X, Li J, et al
    The transcriptional landscape and clinico-biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma.
    Int J Cancer. 2024 Aug 27. doi: 10.1002/ijc.35147.
    PubMed     Abstract available
    
    
    
57. HUANG H, Zhao Y, Deng Y, Zhan Z, et al
    Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study.
    Int J Cancer. 2024 Aug 26. doi: 10.1002/ijc.35139.
    PubMed     Abstract available
    
    
    July 2024
58. WENG Z, Mai Z, Yuan J, Liu Q, et al
    Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy.
    Int J Cancer. 2024 Jul 31. doi: 10.1002/ijc.35118.
    PubMed     Abstract available
    
    
    
59. LAURITZEN BB, Gronlund MW, Jakobsen KK, Justesen MM, et al
    Epidemiological trends and survival of oropharyngeal cancer in a high HPV-prevalent area: A Danish population-based study from 2000 to 2020.
    Int J Cancer. 2024 Jul 17. doi: 10.1002/ijc.35099.
    PubMed     Abstract available
    
    
    
60. WANG R, Chen XZ
    Comment on "Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study".
    Int J Cancer. 2024;155:184-185.
    PubMed    
    
    
    June 2024
61. MA L, Wang TM, He YQ, Liao Y, et al
    Multiplex assays reveal anti-EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma.
    Int J Cancer. 2024 Jun 18. doi: 10.1002/ijc.35061.
    PubMed     Abstract available
    
    
    
62. SUN X, Lin X, Yao J, Tian T, et al
    Potential causal links of long-term exposure to PM(2.5) and its chemical components with the risk of nasopharyngeal carcinoma recurrence: A 10-year cohort study in South China.
    Int J Cancer. 2024 Jun 11. doi: 10.1002/ijc.35047.
    PubMed     Abstract available
    
    
    May 2024
63. GUO D, Jin J, Li D, He Y, et al
    Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan.
    Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35003.
    PubMed     Abstract available
    
    
    
64. HUI Z, Wang B, Liu Z, Wei J, et al
    TGFbeta-induced EN1 promotes tumor budding of adenoid cystic carcinoma in patient-derived organoid model.
    Int J Cancer. 2024;154:1814-1827.
    PubMed     Abstract available
    
    
    
65. KITAHARA CM, Surcel HM, Falk R, Pfeiffer RM, et al
    Early-pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity, and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort.
    Int J Cancer. 2024 May 2. doi: 10.1002/ijc.34974.
    PubMed     Abstract available
    
    
    
66. FANG F, Ritz B, Rao J, Zhu Y, et al
    Association between ambient exposure to PM(2.5) and upper aerodigestive tract cancer in Los Angeles.
    Int J Cancer. 2024;154:1579-1586.
    PubMed     Abstract available
    
    
    April 2024
67. VASILIADOU I, Grose D, Wilson C, Thapa A, et al
    The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
    Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34963.
    PubMed     Abstract available
    
    
    
68. BUDUKH A, Dora T, Sancheti S, Singh V, et al
    Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India.
    Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966.
    PubMed     Abstract available
    
    
    
69. NAKAGAWA T, Santos J, Nasamran CA, Sen P, et al
    Defining the relationship of salivary gland malignancies to novel cell subpopulations in human salivary glands using single nucleus RNA-sequencing.
    Int J Cancer. 2024;154:1492-1503.
    PubMed     Abstract available
    
    
    
70. DI W, Yu J, Zong D, Ge Y, et al
    Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China.
    Int J Cancer. 2024 Apr 10. doi: 10.1002/ijc.34933.
    PubMed     Abstract available
    
    
    
71. SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al
    Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919.
    PubMed     Abstract available
    
    
    
72. LEE JH, Ming Z, Cheung VKY, Pedersen B, et al
    Ex vivo tissue modelling informs drug selection for rare cancers.
    Int J Cancer. 2024;154:1158-1163.
    PubMed     Abstract available
    
    
    March 2024
73. CHARTERS E, Cheng K, Dunn M, Heng C, et al
    Restorabite: Phase II trial of jaw stretching exercises using a novel device for patients with trismus following head and neck cancer.
    Int J Cancer. 2024 Mar 31. doi: 10.1002/ijc.34941.
    PubMed     Abstract available
    
    
    
74. DOHERTY N, Cardwell C, Murchie P, Hill C, et al
    Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population-based cohort study.
    Int J Cancer. 2024 Mar 30. doi: 10.1002/ijc.34937.
    PubMed     Abstract available
    
    
    
75. MADRIGAL JM, Troisi R, Surcel HM, Ohman H, et al
    Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
    Int J Cancer. 2024;154:979-991.
    PubMed     Abstract available
    
    
    
76. LU Y, Clifford GM, Fairley CK, Grulich AE, et al
    Human papillomavirus and p16(INK4a) in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2024;154:830-841.
    PubMed     Abstract available
    
    
    February 2024
77. RINALDI S, Dossus L, Keski-Rahkonen P, Kiss A, et al
    Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
    Int J Cancer. 2024 Feb 15. doi: 10.1002/ijc.34872.
    PubMed     Abstract available
    
    
    
78. SEYYEDSALEHI MS, Boffetta P
    Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Feb 10. doi: 10.1002/ijc.34881.
    PubMed     Abstract available
    
    
    
79. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
    Int J Cancer. 2024 Feb 5. doi: 10.1002/ijc.34861.
    PubMed     Abstract available
    
    
    January 2024
80. KAIMILA B, Yano Y, Mulima G, Chen Y, et al
    Poor oral health and the risk of esophageal squamous cell carcinoma in Malawi.
    Int J Cancer. 2024 Jan 9. doi: 10.1002/ijc.34829.
    PubMed     Abstract available
    
    
    November 2023
81. STUART CM, Meguid RA, Bronsert MR, Rodriguez Franco S, et al
    The United States experience with diagnosing and treating esophageal cancer during the SARS-CoV-2 pandemic: A retrospective cohort study.
    Int J Cancer. 2023 Nov 28. doi: 10.1002/ijc.34805.
    PubMed     Abstract available
    
    
    
82. 
    Correction to "A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers".
    Int J Cancer. 2023 Nov 19. doi: 10.1002/ijc.34789.
    PubMed    
    
    
    
83. RANGEL-POZZO A, Dos Santos FF, Dettori T, Giulietti M, et al
    Three-dimensional nuclear architecture distinguishes thyroid cancer histotypes.
    Int J Cancer. 2023;153:1842-1853.
    PubMed     Abstract available
    
    
    October 2023
84. DOCHI H, Kondo S, Komura S, Moriyama-Kita M, et al
    Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.
    Int J Cancer. 2023 Oct 31. doi: 10.1002/ijc.34777.
    PubMed     Abstract available
    
    
    September 2023
85. RAN X, Zeng H, Zheng R, Sun K, et al
    Geographic, sex and socioeconomic disparities in esophageal cancer incidence in China: A population-based study.
    Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34730.
    PubMed     Abstract available
    
    
    
86. SCOBIOALA S, Parfitt R, Matulat P, Byrne J, et al
    The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34732.
    PubMed     Abstract available
    
    
    
87. KUSTERS JMA, Diergaarde B, Ness A, Schim van der Loeff MF, et al
    Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
    Int J Cancer. 2023 Sep 11. doi: 10.1002/ijc.34710.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.